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Background: Several environmental exposures, including infection with Epstein-Barr virus, low levels of vitamin D
and smoking are established risk factors for multiple sclerosis (MS). Also, high hygienic standard and infection with
parasites have been proposed to influence MS risk. The aim of this study was to investigate the influence of various
environmental exposures on MS risk in a Norwegian cohort, focusing on factors during childhood related to the
hygiene hypothesis.
Methods: A questionnaire concerning environmental exposures, lifestyle, demographics and comorbidity was
administrated to 756 Norwegian MS patients and 1090 healthy controls. Logistic regression was used to calculate
odds ratio (OR) with 95% confidence interval (CI) for the risk of MS associated with the variables infectious
mononucleosis, severe infection during childhood, vaccination and animals in the household during childhood.
Age, gender, HLA-DRB1*15:01, smoking and infectious mononucleosis were included as covariates. General
environmental exposures, including tobacco use, were also evaluated.
Results: Infectious mononucleosis was confirmed to be significantly associated with increased MS risk, also after
adjusting for the covariates (OR = 1.79, 95% CI: 1.12-2.87, p = 0.016). The controls more often reported growing up
with a cat and/or a dog in the household, and this was significant for ownership of cat also after adjusting for the
covariates (OR = 0.56, 95% CI: 0.40-0.78, p = 0.001). More patients than controls reported smoking and fewer patients
reported snuff use.
Conclusions: In this Norwegian MS case–control study of environmental exposures, we replicate that infectious
mononucleosis and smoking are associated with increased MS risk. Our data also indicate a protective effect on MS
of exposure to cats during childhood, in accordance with the hypothesis that risk of autoimmune diseases like MS
may increase with high hygienic standard.
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Multiple sclerosis (MS) is an inflammatory disease of the
central nervous system often affecting young adults [1].
Several environmental exposures have been associated
with increased risk of developing MS, the best estab-
lished are infection with Epstein-Barr virus (EBV), low
levels of vitamin D and smoking [2]. The genetic back-
ground of MS is complex, and both HLA and non-HLA
genes are known to influence the disease susceptibility
[3]. HLA-DRB1*15:01 is the major risk allele for MS
with an odds ratio (OR) of 3.1, whereas HLA-A*02:01
has been shown to have an independent protective effect
with an OR of 0.73 [4]. Recently, 110 non-HLA MS
susceptibility loci have been identified [4,5], all with rela-
tively low ORs. The majority of the non-HLA loci
are associated with immunologically relevant genes,
supporting that MS primarily is an immune mediated
disease.
Tobacco use and exposure have also been related to
MS in several studies [2]. Smokers have an increased
risk of MS, which also seems to increase with cumula-
tive dose [6]. This association is not found for snuff
use [6], which even has been suggested to have a pro-
tective effect on MS susceptibility [7]. Further, expos-
ure to passive smoke has been suggested to negatively
influence MS risk [8]. An interaction between smok-
ing and the strongest genetic risk factors (carriage of
HLA-DRB1*15 and absence of HLA-A*02) has been
observed [9], indicating that this environmental ex-
posure could have a stronger influence on genetically
susceptible individuals.
EBV is a herpes virus infecting more than 90% of
humans and the virus persists within the B lymphocytes
after the infection [10]. A history of infectious mono-
nucleosis (IM), the clinical manifestation of infection
with EBV, is reported to give two to threefold increased
risk of MS [11] and EBV seronegative individuals have a
very low risk of MS [2]. Since infection with EBV in
childhood often is asymptomatic, an episode of IM has
been suggested as an indicator of low exposures to infec-
tions early in life [11]. Further, an interaction between
antibodies against EBV nuclear antigen 1 and HLA-
DRB1*15:01 status has been suggested [12,13].
MS affects more women than men, and the female to
male ratio is increasing [14]. It has been hypothesized
that oestrogen could have a protective role in MS [15]
and an interaction between oestrogen and vitamin D has
been suggested [16].
The prevalence of autoimmune diseases in general has
increased in industrialized countries, and a reduction
of exposure to pathogens early in life as a consequence
of better hygienic standard has been proposed as a
possible explanation for this, i.e. the hygiene hypoth-
esis [17]. A relationship between MS risk and highsanitation standard was suggested as early as in the
1960s [18]. Parasite infections modulate the immune
response in the host, and a possible protective effect
of helminthic infections on disease progression in MS
has been described [19]. Both cats and dogs are known
hosts of parasites that can be transferred to humans [20],
and households with animals have increased endotoxin
levels in the house dust compared to households without
animals [21]. Exposure to animals in relation to MS risk
has previously been evaluated in some studies, but the
findings are conflicting [22-26].
In this case–control study, we wanted to determine the
frequency of various environmental exposures and lifestyle
factors in a clinically and genetically well-characterized
Norwegian MS cohort. We aimed both to replicate estab-
lished risk factors and to investigate more recently sug-
gested environmental exposures, with a main focus
on exposures during childhood related to the hygiene
hypothesis, such as severe infections, vaccinations and ex-
posure to animals, hypothesizing that these exposures
could influence inflammatory responses and thereby MS
susceptibility.
Methods
Subjects and study design
MS patients (n = 756) from the Oslo MS Registry and
randomly selected healthy controls (n = 1090) from the
Norwegian Bone Marrow Donor Registry were invited in
2011/2012 to participate in this case–control study. The
MS patients were diagnosed in accordance with the
Poser and/or McDonald criteria [27,28]. The Oslo MS
Registry and biobank has been built up over the last
24 years, and includes clinical data and DNA samples
from a general, population based MS cohort [29], re-
cruited from the largest MS clinic in Norway. The
Norwegian Bone Marrow Donor Registry is a nation-
wide registry of blood donors who have consented to
donate stem cells. Informed written consent was ob-
tained from all the participants. The study was approved
by the Regional Committee for Medical and Health
Research Ethics South East.
A standardized questionnaire concerning lifestyle fac-
tors and background information was designed based on
previously tested questionnaires [6,30,31]. This included
questions about smoking, snuff use, exposure to passive
smoke, animals in the household before the age of 18
(dog, cat, horse or other animals), IM, autoimmune co-
morbidity (type 1 diabetes, psoriasis, rheumatoid arthritis,
ankylosing spondylitis, sarcoidosis, myasthenia gravis, ce-
liac disease, inflammatory bowel disease, primary scleros-
ing cholangitis, systemic lupus erythematosus, Sjögren’s
syndrome, hypothyroidism or hyperthyroidism), questions
concerning female reproductive health, education level and
current employment. In addition, a question concerning
Table 1 Background characteristics of patients and controls
MS patients
(n = 530)
Controls
(n = 918)
Demographic characteristics
Female gender, n (%) 391 (73.8) 535 (58.3)
Age, mean (SD) 50.5 (12.7) 44.0 (6.9)
College/university, 4 years or more, n (%) 177 (33.6) 293 (32.5)
Nordic ethnicity, n (%) 487 (92.8) 877 (96.8)
Employed, n (%) 279 (52.8) 836 (95.7)
Genetic characteristics
HLA-DRB1*15:01 positive, n (%) 186 (58.3) 263 (29.0)
Clinical characteristics
Relapsing remitting onset, n (%) 454 (88.7) -
Age at onset, mean (SD) 32.3 (9.3) -
Disease duration, mean (SD) 18.2 (11.6) -
Oligoclonal band status in cerebrospinal
fluid positive, n (%)
448 (88.9) -
EDSS, median (range) 3.0 (0–9) -
MSSS, median (range) 3.25 (0–10) -
Abbreviations: SD = Standard deviation, EDSS = Expanded Disability Status
Scale, MSSS = Multiple Sclerosis Severity Score.
Missing values are not included in the calculations.
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(pneumonia, urinary tract infection, gastrointestinal in-
fection, meningitis and/or encephalitis or other disease)
was included. To evaluate the questionnaire, a test-
retest was performed in 50 healthy subjects who were
given the questionnaire twice with an interval of four
weeks. The questionnaire was sent by mail to MS pa-
tients (n = 690) and controls (n = 1090) in 2011. Non re-
sponders received two reminders. In addition, 66 recently
diagnosed MS patients were given the questionnaire dir-
ectly when participating in another on-going study in
2012. The questionnaire was designed in the Cardiff
TeleForm software and scanned in the same system. As
quality control of the scanning process, 10% of the ques-
tionnaires were manually inspected.
Genotyping
HLA-DRB1 genotypes at four digit resolution were avail-
able for 319 patients and 908 controls, either obtained
by a sequence based approach (nms = 75, ncontrols = 908)
[32] or imputed using HLA*IMP2 [33] for samples in-
cluded in the Immunochip project [5] (nms = 244).
Statistical analyses
Pearson’s Chi-square test and two sided t-test were
used to analyse the personal and lifestyle related char-
acteristics concerning tobacco use and exposure, co-
morbidity and female reproductive health. Logistic
regression was used to calculate OR with 95% confi-
dence interval (CI) for the risk of MS associated with
the following exposure variables; IM, hospitalization
for infection before the age of 18, participation in the
childhood immunisation programme and animals in
the household before the age of 18. Age, gender, HLA-
DRB1*15:01 carrier status (present/not present), and
the established environmental risk factors smoking
(divided into ever smoker (daily and occasionally use
combined) and never smoker) and episode with IM
were included as covariates in multivariate logistic re-
gression analyses. Information of vitamin D status was
not available and could therefore not be adjusted for.
Age was stratified into quartiles (<39, 39–45, 46–52
and > 52) to obtain linearity in the logit, and was
thus analysed as a categorical variable. The exposure
variables were in addition analysed in patients and
controls < 60 years (nms = 398, ncontrols = 914) with lo-
gistic regression adjusted for age (as a continuous
variable), gender, smoking, IM and HLA-DRB1*15:01
status. Also, analyses of the significantly associated en-
vironmental exposures IM, ownership of cat or dog,
smoking and snuff use were done in groups stratified
on HLA-DRB1*15:01 carrier status. Analyses were con-
ducted using IBM SPSS version 22 and a significance
level of 5% was used for all analyses.Results
Background characteristics
The total response rate was 70.1% (n = 530) in the MS
patients and 84.2% (n = 918) in the controls. The demo-
graphic, genetic and clinical characteristics are pre-
sented in Table 1. There were more females among
the patients (73.8%) than among the controls (58.3%),
and the patient group had a higher mean age at inclu-
sion in this study (50.5 vs. 44.0 years). The groups did
not differ with regard to education level, but more con-
trols than patients reported to currently be employed.
The HLA-DRB1*15:01 allele was more frequently car-
ried by the patients than the controls (58.3% vs. 29.0%,
punadjusted = 8.03 × 10
−21).
Table 2 presents personal and lifestyle related charac-
teristics for patients and controls. Smoking was signi-
ficantly associated with increased MS risk. Of the
patients, 74.5% reported to ever having smoked com-
pared to 54.8% of the controls (punadjusted = 1.15 × 10
−13).
Further, 11.4% of the patients and 15.6% of the controls
reported to ever having used snuff (punadjusted = 0.029).
No significant association to MS of exposure to passive
smoke was seen. The groups did not differ with regard
to autoimmune comorbidity, and no significant differ-
ences were detected with regard to tonsillectomy and
appendectomy. Age at menarche and age when giving
birth to their first child did not differ significantly be-
tween the female patients and controls, but the patients
reported a significantly lower parity rate than the con-
trols (1.21 vs. 1.77, punadjusted = 4.89 × 10
−14).
Table 2 Personal and lifestyle characteristics of included
MS patients and controls
MS patients
(n = 530)
Controls
(n = 918)
Crude
p-value
Tobacco use and exposure
Ever smoker, n (%) 386 (74.5) 495 (54.8) 1.15×10-13a
Ever snuff use, n (%) 60 (11.4) 141 (15.6) 0.029a
Ever exposure to passive smoke,
n (%)
380 (72.2) 652 (72.0) 0.94a
Comorbidity
Autoimmune disease other than
MS, n (%)
85 (16.0) 151 (16.4) 0.84a
Tonsillectomy, n (%) 118 (23.2) 174 (19.3) 0.078a
Appendectomy, n (%) 60 (11.8) 106 (11.8) 1.0a
Female reproductive health*
Age at menarche, mean (SD) 13.07 (1.38) 12.97 (1.43) 0.28b
Number of children, mean (SD) 1.21 (1.07) 1.77 (1.12) 4.89×10-14b
Age at first child, mean (SD) 27.34 (5.50) 27.05 (4.79) 0.47b
Abbreviation: SD = Standard deviation.
aPearson’s Chi square test.
btwo sided t-test.
*Only women included (ncases = 391, ncontrols = 535).
Missing values are not included in the calculations.
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and adolescence
Logistic regression analyses for environmental expo-
sures during childhood and adolescence are presented
in Table 3. A history of IM was significantly associ-
ated with increased MS risk, also after adjusting forTable 3 Environmental exposures during childhood and adol
MS patie
(n = 530
Infectious mononucleosis, n (%)* 84 (19.0)
Hospitalized for infection before age 18, n (%)
Pneumonia 16 (3.1)
Urinary tract/kidney infection 16 (3.1)
Gastrointestinal infection 7 (1.3)
Encephalitis/meningitis 10 (1.9)
Other infection 27 (5.2)
Participation in childhood immunisation programme, n (%) 490 (98.8
Household pets before age 18, n (%)
Cat 207 (39.7
Dog 192 (36.9
Horse 32 (6.1)
Other animal 138 (26.5
Abbreviations: SD = Standard deviation, OR = Odds ratio, CI = Confidence interval.
aLogistic regression, unadjusted.
bLogistic regression adjusted for age (stratified into following quartiles: < 39, 39–45
HLA-DRB1*15:01 status.
*Not adjusted for mononucleosis.
Missing values are not included in the calculations.age, gender, smoking and HLA-DRB1*15:01 status
(OR = 1.79, 95% CI: 1.12-2.87, p = 0.016) when analys-
ing all available data. Similar results were obtained
when only including patients and controls < 60 years
(OR = 1.88, 95% CI: 1.15-3.06, p = 0.012). The fre-
quency of hospitalization for severe infection before
age 18 did not differ between the groups, with excep-
tion of meningitis/encephalitis which was more often re-
ported by the patients (1.9% vs. 0.3%, punadjusted = 0.007),
but significance was not retrieved in the adjusted
analysis. Participation in the childhood immunisation
programme was equally high both for patients and
controls (98.8% vs. 99.0%, punadjusted = 0.75). The pa-
tients less often reported to have had a cat or a dog
in the household before age 18 compared to the healthy
controls (39.7% vs. 51.0%, punadjusted = 3.6 × 10
−5 and
36.9% vs. 47.1%, punadjusted = 1.73 × 10
−4, respectively).
This remained significant for ownership of cat after
adjusting for the covariates (OR = 0.56, 95% CI: 0.40-
0.78, p = 0.001), but significance for dog ownership
was not retrieved in the adjusted analysis. When only
including patients and controls < 60 years in this ana-
lysis, both cat and dog ownership were significantly
associated in the unadjusted analysis (OR = 0.66, 95%
CI: 0.52-0.85, p = 0.001, OR = 0.70, 95% CI: 0.55-0.90,
p = 0.005, respectively), but only ownership of cat
remained significant after adjusting for the covariates
(OR = 0.59, 95% CI: 0.41-0.84, p = 0.004). The groups
did not differ with regard to ownership of horse or other
animals.escence in patients and controls
nts Controls Unadjusted analysisa Adjusted analysisb
) (n = 918) p-value, OR (95% CI) p-value, OR (95% CI)
106 (12.3) 0.001, 1.69 (1.23-2.30) 0.016, 1.79 (1.12-2.87)
23 (2.5) 0.55, 1.22 (0.64-2.33) 0.67, 1.26 (0.45-3.56)
25 (2.7) 0.73, 1.12 (0.59-2.12) 0.43, 0.64 (0.22-1.91)
15 (1.6) 0.65, 0.81 (0.33-2.00) 0.36, 0.35 (0.038-3.28)
3 (0.3) 0.007, 5.91 (1.62-21.58) 0.76, 1.56 (0.95-23.37)
37 (4.1) 0.33, 1.29 (0.78-2.14) 0.78, 1.10 (0.55-2.23)
) 873 (99.0) 0.75, 0.84 (0.30-2.38) 0.88, 1.14 (0.21-6.20)
) 463 (51.0) 3.6x10−5, 0.63 (0.51-0.79) 0.001, 0.56 (0.40-0.78)
) 427 (47.1) 1.73x10−4, 0.66 (0.53-0.82) 0.060, 0.73 (0.52-1.01)
63 (6.9) 0.54, 0.87 (0.56-1.35) 0.64, 0.86 (0.47-1.59)
) 240 (26.5) 1.0, 1.0 (0.78-1.28) 0.85, 1.04 (0.71-1.52)
, 46–52 and > 52), gender, smoking status, mononucleosis and
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The environmental exposures which were significantly
associated with MS in the unadjusted analyses (smoking,
snuff use, IM and ownership of cat or dog before age 18)
were also analysed with logistic regression adjusting for
age, gender, IM and smoking in groups stratified on
HLA-DRB1*15:01 carrier status (present/not present).
All exposures showed significant association in MS pa-
tients carrying HLA-DRB1*15:01 allele, while only smok-
ing was significantly associated in patients without this
high risk HLA allele (Table 4). Importantly, the ORs and
CIs overlapped between these two strata.
Discussion
This study presents an extensive characterization of 530
Norwegian MS patients and 918 healthy controls with
regard to environmental exposures, lifestyle factors and
sociodemographic background. The observations con-
firm that IM and smoking are risk factors for MS also in
a Norwegian cohort, and indicate that less studied envir-
onmental exposures, such as exposure to animals during
childhood, could also influence MS susceptibility.
Environmental case–control studies are prone to di-
verse biases. In order to minimize a potential recall bias,
the participants were not informed about the main
hypotheses, and patients and controls received identi-
cal questionnaires. The selection of controls from the
National Bone Marrow Donor Registry may have caused
a selection bias towards a more than normally healthy
control group. We do, however, note that educational
level and comorbidity were similar in the patient and
control groups, indicating that the groups are compar-
able with regard to socioeconomic status and thus prob-
ably also general health. Also, the percentage of present,
daily smokers among the healthy controls was 16.7%
(data not shown), which is equal to the frequency in the
general Norwegian population [34], arguing for that the
controls are representative with regard to lifestyle factors.Table 4 Environmental exposures in patients and controls str
HLA-DRB1*15:01 +
(nMS = 186/nC = 263)
HLA-D
(nMS =
Unadjusted analysisa
p-value, OR (95% CI)
Unad
p-valu
Smoking status* 4.0×10−6, 2.76 (1.79-4.24) 1.1×10
Snuff use 0.006, 0.41 (0.22-0.77) 0.065,
Infectious mononucleosis** 0.25, 1.46 (0.77-2.77) 0.36, 1
Cat in the household before age 18 8.0×10−5, 0.46 (0.31-0.68) 0.062,
Dog in the household before age 18 0.013, 0.61 (0.42-0.90) 0.28, 0
Abbreviations: SD = Standard deviation, OR = Odds ratio, CI = Confidence interval, n
aLogistic regression, unadjusted.
bLogistic regression, adjusted for age, gender, smoking status and mononucleosis.
*Not adjusted for smoking status.
**Not adjusted for mononucleosis.Since the patients and controls as expected differed with
regard to age and gender distribution, age and gender
were included as covariates in the adjusted analyses.
Moreover, information about established environmental
and genetic risk factors for MS; smoking status, IM and
HLA-DRB1*15:01, was available for a large fraction of
the included individuals. Thus, we were able to adjust for
these factors in the analyses, and also sub-analyses strati-
fied for HLA-DRB1*15:01 carrier status could be con-
ducted. Analyses for gene-environment interactions were
not performed due to insufficient power. The analyses
were not adjusted for vitamin D status and BMI, which
could represent a limitation of the study. However, the
relatively large number of participants and high response
rates in both the patient and control groups are strengths
of this study.
Smoking is an established risk factor for MS, but the
mechanisms behind this association is still unclear [2,6].
The observations in the present study cohort, with a sig-
nificantly higher proportion of the MS patients than
controls reporting to be ever smokers, support that
smoking increases MS risk. Further, in line with findings
in a recent Swedish case–control study [7], we note that
the patients less frequently reported snuff use. We found
no significant association between the patients and con-
trols for exposure to passive smoke, in contrast to some
other reports [8].
Moreover, female reproductive factors have been in-
vestigated in relation to MS in several studies [35]. An
early age at menarche has been suggested as a risk fac-
tor for MS [36], but the findings in the present study
do not support this. We did, however, find a lower par-
ity rate among the patients. It has previously been sug-
gested that pregnancy and high parity could protect
against MS [37,38], but the findings are conflicting [39].
Other factors, such as avoiding or postponing preg-
nancy due to concerns related to the disease or use of
medications, must also be taken into consideration. Inatified on HLA-DRB1*15:01 carrier status
RB1*15:01 -
133/nC = 645)
HLA-DRB1*15:01 +
(nMS = 186/nC = 263)
HLA-DRB1*15:01 -
(nMS = 133/nC = 645)
justed analysisa
e, OR (95% CI)
Adjusted analysisb
p-value, OR (95% CI)
Adjusted analysisb
p-value, OR (95% CI)
−5, 2.62 (1.71-4.02) 2.02×10−4, 2.67 (1.59-4.48) 0.008, 2.01 (1.20-3.34)
0.55 (0.29-1.04) 0.20, 0.60 (0.27-1.32) 0.76, 0.88 (0.39-2.0)
.29 (0.75-2.23) 0.033, 2.22 (1.07-4.61) 0.18, 1.55 (0.82-2.95)
0.69 (0.47-1.02) 1.83×10−4, 0.41 (0.25-0.65) 0.26, 0.76 (0.48-1.22)
.81 (0.56-1.19) 0.052, 0.63 (0.39-1.01) 0.43, 0.83 (0.52-1.32)
C = ncontrols.
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fertility [40].
In contrast to others [41,42], we found no differences
between the patients and controls in the frequency of
tonsillectomy, appendectomy or other autoimmune dis-
eases than MS.
In this study, we observed that the controls more often
were exposed to cats and/or dogs during childhood
compared to the patients. Interestingly, when stratifying
for HLA-DRB1*15:01 carrier status, exposure to cats
was only significantly different in the HLA-DRB1*15:01
positive group. This trend was also seen for dog expos-
ure. An association between infection with the parasite
Toxoplasma gondii (T. gondii), (common in cats), and
MS has recently been suggested [43]. T. gondii interacts
with a number of genes in the host during an infection,
and the study shows a large overlap of these genes with
MS susceptibility genes. The biological implication of
this observation is unclear. However, T. gondii is known
to affect both pro-inflammatory and anti-inflammatory
processes in the host [44], and this could theoretically
influence MS susceptibility. Some previous studies have
investigated exposures to animals in relation to MS risk,
with conflicting findings [22-26]. In accordance with our
observations, a protective effect of cat exposure on MS
risk has been suggested in a Canadian case–control
study including 200 MS patients and 202 controls, and
this effect was even stronger in those who reported cat
ownership for 10 years or more [24]. On the other hand,
a positive correlation of MS risk and exposure to dogs
has been suggested in some small studies [22,23]. Finally,
others have not found an association between MS risk
and exposure to household pets [25,26]. An Iranian
case–control study of 394 MS patients and 394 controls
did not detect any influence of exposure to animals on
MS risk [25], and this was further supported by a Ger-
man study among 245 MS patients and 296 controls
[26]. The differences between the findings in the present
study and these other studies could be due to better
power in the present study. In addition, differences in
the control groups among the German, Iranian and this
Norwegian study may contribute to different results.
Several aspects must be kept in mind regarding our ob-
servation of more exposure to cats and dogs in healthy
controls than in MS patients. Presumably more outdoor
activity and exercise in pet owners may reduce the risk
of MS, by leading to higher levels of vitamin D and
lower body weight. It should also be emphasized that a
larger amount of the patients than the controls in the
present study lived in or nearby Oslo, the capital of
Norway, and this could be a potential bias when investi-
gating ownership of household pets. Information of
place of residency when growing up was not available in
this study, thus the analyses could not be adjusted forlevel of urbanization. Notably, it has previously been
shown that only 46.1% of the MS patients living in Oslo
were born in Oslo [29].
Our findings add support to the suggested relationship
between infection with EBV and MS [11,12]. Of the pa-
tients, 19.0% reported to have had IM compared to
12.3% of the healthy controls. An episode of IM could
be an indicator of low exposures to infections early in
life, since infection with EBV during childhood often is
asymptomatic. The fact that EBV negative individuals
(who may be assumed to have the highest level of hy-
giene) have very low MS risk could be considered as not
in accordance with the hygiene hypothesis. However, an
increased MS susceptibility due to few infections early in
life could potentially be manifested only after infection
with EBV [2].
Also, common childhood infections in relation to MS
risk have been investigated in numerous studies [23-25,45],
but severe infections during childhood are less studied.
We did not detect any consistent significant differences,
but an effect could have been missed due to modest
power or recall bias. Further, both patients and controls
reported similar participation in the childhood immun-
isation programme, supporting that childhood vaccina-
tions do not increase the risk of MS, in accordance
with previous findings [46].
Conclusions
The observations in the present study both confirm the
influence on MS risk of previously suggested environ-
mental exposures such as smoking and IM and point to
less established factors related to the hygiene hypothesis,
like growing up with a cat in the household. The bio-
logical mechanisms behind these observations should be
further investigated.
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